<DOC>
	<DOCNO>NCT02563184</DOCNO>
	<brief_summary>To evaluate magnitude humoral immune response quadrivalent vs trivalent influenza vaccine adult age 50 64 year prior diagnosis GOLD Stage C D COPD vs. patient without COPD .</brief_summary>
	<brief_title>Seasonal Influenza Vaccine , Quadrivalent Versus Trivalent Patients With Advanced Chronic Obstructive Pulmonary Disease</brief_title>
	<detailed_description>Primary Objectives : To evaluate magnitude humoral immune response quadrivalent vs trivalent influenza vaccine adult age 50 64 year prior diagnosis GOLD Stage C D COPD ( vs. patient without COPD ) . To demonstrate immunogenicity measure hemagglutination inhibit antibody ( HI ) components viral antigen use seroconversion ( ≥4 fold increase baseline titer ) sero-protection ( HI titer ≥40 vaccine component ) . Secondary Objective : To assess degree antibody response COPD patient base severity disease measure FEV1 . To assess impact inhaled corticosteroid adaptive immune response vaccination .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Inclusion criterion patient COPD : 1 . Signed informed consent prior initiation studymandated vaccination . 2 . Patients spirometric data precede 18 month confirm diagnosis COPD . 3 . Patients meet GOLD Classification Stage C Stage D COPD . 4 . Patients 50 year old 64 year old . Inclusion criterion Healthy participant : 1 . Signed informed consent prior initiation studymandated vaccination . 2 . No active symptom lung disease . 3 . FEV1/FVC normal range &gt; 70 % age predict value . 4 . No history tobacco use/abuse . 5 . No prior history alpha1 antitrypsin deficiency . 6 . Patients 50 year old 64 year old . 1 . Severe allergy egg . 2 . Severe reaction past dos influenza vaccine . 3 . GuillianBarre syndrome . 4 . Currently recieving dialysis . 5 . Current , active , treatment cancer . 6 . History transplant ( allograft ) . 7 . Dementia Alzheimer 's disease diagnosis . 8 . Prior diagnosis HIV AIDS . 9 . Moderate severe pulmonary hypertension . 10 . Serum AST/ALT &gt; 3x upper limit normal . 11 . Patients exacerbation respiratory infection 4 week precede onset study . 12 . Active pregnancy . 13 . Systemic immunomodulating medication .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>